TELA Bio to Participate in Upcoming Needham Virtual Growth Conference

MALVERN, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company will participate in the 23rd Annual Needham Virtual Growth Conference.

TELA Bio's management is also scheduled to present at the Needham Virtual Growth Conference on Friday, January 15, 2021 at 2:45 PM EST. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.

TELA Bio, Inc. is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. TELA's products are designed to improve on shortcomings of existing biologics and minimize long-term exposure to permanent synthetic material. TELA's portfolio is supported by quality, data-driven science and extensive pre-clinical research that has consistently demonstrated advantages over other commercially available products.

TELA Bio ContactStuart HendersonVice President, Corporate Development and Investor RelationsTELA Bio, Inc.484-320-2930

Investor ContactGreg Chodaczek347-620-7010 [email protected]

You May Also Be Interested In

• Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
• Dimensional Fund Advisors Ltd. : Form 8.3 - GAMMA COMMUNICATIONS PLC - Ordinary Shares
• Dimensional Fund Advisors Ltd. : Form 8.3 - DCC PLC - Ordinary Shares